PML and triple-negative breast carcinoma: We and others have demonstrated that PML is overexpressed in triple-negative breast cancer (TNBC) where it displays oncogenic functions by promoting pro-tumoral metabolism, cancer stem cell maintenance and metastasis (14–17).